Sorrento Therapeutics, Inc. carries a market capitalization of 16.54M, placing it among publicly traded companies globally.
| Market Cap | 16.54M |
| Enterprise Value | N/A |
Sorrento Therapeutics, Inc.'s stock has declined approximately -85.22167% over the past 52 weeks. The 50-day moving average sits at 0.02, while the 200-day moving average is 0.09.
| Beta (5Y) | N/A |
| 52-Week Price Change | -85.22167% |
| 50-Day Moving Average | 0.02 |
| 200-Day Moving Average | 0.09 |
| Average Volume (20 Days) | N/A |
Sorrento Therapeutics, Inc.'s most recent stock split took place on August 1, 2013 with a 25:1 split ratio.
| Last Split Date | 8/1/2013 |
| Split Ratio | 25:1 |